Document Detail


Ventricular tachycardia in infants with structurally normal heart: a benign disorder.
MedLine Citation:
PMID:  20723269     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We evaluated the presentation, treatment, and outcome of infants who present with ventricular tachycardia in the first year of life. Seventy-six infants were admitted to our institution with a diagnosis of ventricular tachycardia between January, 1987 and May, 2006. Forty-five infants were excluded from the study because of additional confounding diagnoses including accelerated idioventricular rhythm, Wolff-Parkinson-White syndrome, supraventricular tachycardia with aberrancy, long QT syndrome, cardiac rhabdomyoma, myocarditis, congenital lesions, or incomplete data. The remaining 31 included infants who had a median age at presentation of 1 day, with a range from 1 to 255 days, and a mean ventricular tachycardia rate of 213 beats per minute, with a range from 171 to 280, at presentation. The infants were treated chronically with propranolol (38.7%), amiodarone (12.9%), mexiletine (3.2%), propranolol and mexiletine (9.7%), or propranolol and procainamide (6.5%). The median duration of treatment was 13 months, with a range from 3 to 105 months. Ventricular tachycardia resolved spontaneously in all infants. No patient died, or received catheter ablation or device therapy. Median age at last ventricular tachycardia was 59 days, with a range from 1 to 836 days. Mean follow-up was 45 months, with a range from 5 to 164 months, with a mean ventricular tachycardia-free period of 40 months. Infants with asymptomatic ventricular tachycardia, a structurally normal heart, and no additional electrophysiological diagnosis all had spontaneous resolution of tachycardia. Furthermore, log-rank analysis of the time to ventricular tachycardia resolution showed no difference between children who received chronic outpatient anti-arrhythmic treatment and those who had no such therapy. While indications for therapy cannot be determined from this study, lack of symptoms or myocardial dysfunction suggests that therapy may not be necessary.
Authors:
Mark D Levin; Paul Stephens; Ronn E Tanel; Victoria L Vetter; Larry A Rhodes
Related Documents :
492629 - Maternal and neonatal implications of congenital complete heart block in the fetus.
16516699 - Correlates of b-type natriuretic peptide and 6-min walk in heart failure patients.
7302749 - Choanal atresia and congenital heart disease.
7315299 - Gastric emptying in infants with congenital heart disease.
11824959 - Neonatal lupus manifests as isolated neutropenia and mildly abnormal liver functions.
17394449 - Surface electrocardiographic patterns and electrophysiologic characteristics of atrial ...
11019779 - Targeting adolescent mothers with depressive symptoms for early intervention.
11723859 - Paralytic ileus in a mechanically ventilated preterm infant treated with fentanyl.
15746019 - Neglect of dropout underestimates effects of death in longitudinal studies.
Publication Detail:
Type:  Journal Article     Date:  2010-08-20
Journal Detail:
Title:  Cardiology in the young     Volume:  20     ISSN:  1467-1107     ISO Abbreviation:  Cardiol Young     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-10-26     Completed Date:  2011-02-10     Revised Date:  2013-08-27    
Medline Journal Info:
Nlm Unique ID:  9200019     Medline TA:  Cardiol Young     Country:  England    
Other Details:
Languages:  eng     Pagination:  641-7     Citation Subset:  IM    
Affiliation:
The Children's Hospital of Philadelphia, Pennsylvania, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Arrhythmia Agents / therapeutic use*
Echocardiography
Electrocardiography
Electrocardiography, Ambulatory
Female
Humans
Infant
Infant, Newborn
Male
Remission, Spontaneous
Survival Analysis
Tachycardia, Ventricular / drug therapy*,  physiopathology
Grant Support
ID/Acronym/Agency:
K08 HL094748/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Anti-Arrhythmia Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Diagnosis and management of bacterial vaginosis and other types of abnormal vaginal bacterial flora:...
Next Document:  Anomalous origin of the pulmonary artery from the aorta: early diagnosis and repair leading to immed...